Regulation of Secondary Antigen-Specific CD8+ T-Cell Responses by Natural Killer T Cells
The physiologic function of natural killer T (NKT) cells in adaptive immunity remains largely unknown because most studies have used NKT cell agonists. In the present study, the role of NKT cells during the secondary effector phase was investigated separately from the primary immunization phase via...
Gespeichert in:
Veröffentlicht in: | Cancer research (Chicago, Ill.) Ill.), 2009-05, Vol.69 (10), p.4301-4308 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 4308 |
---|---|
container_issue | 10 |
container_start_page | 4301 |
container_title | Cancer research (Chicago, Ill.) |
container_volume | 69 |
creator | CHANGWAN HONG LEE, Hyunji PARK, Yoon-Kyung SHIN, Junghoon SUNDO JUNG KIM, Hoyeon HONG, Seokmann PARK, Se-Ho |
description | The physiologic function of natural killer T (NKT) cells in adaptive immunity remains largely unknown because most studies have used NKT cell agonists. In the present study, the role of NKT cells during the secondary effector phase was investigated separately from the primary immunization phase via adoptive transfer of differentiated effector T cells into naive recipients. We found that secondary antitumor CD8(+) T-cell responses were optimal when NKT cells were present. Tumor-specific CD8(+) effector T cells responded less strongly to tumor cell challenge in NKT cell-deficient recipients than in recipients with intact NKT cells. NKT cell-mediated enhancement of the secondary antitumor CD8(+) T-cell response was concurrent with increased number and activity of tumor-specific CD8(+) T cells. These findings provide the first demonstration of a direct role for NKT cells in the regulation of antigen-specific secondary T-cell responses without the use of exogenous NKT cell agonists such as alpha-galactosylceramide (alpha-GalCer). Furthermore, forced activation of NKT cells with alpha-GalCer during the secondary immune response in suboptimally immunized animals enhanced otherwise poor tumor rejection responses. Taken together, our findings strongly emphasize the importance of NKT cells in secondary CD8(+) T-cell immune responses. |
doi_str_mv | 10.1158/0008-5472.CAN-08-1721 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67247808</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67247808</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-16133c0967e114e1760970acee38a4effb1701c4a51bbd32886b94df7572f2863</originalsourceid><addsrcrecordid>eNpFkMlOwzAQQC0EgrJ8AsgXuKAUj2PH7rEKq6iKVIrEzXLccRWUJiVODvw9jqjKaWakN9sj5BLYGEDqO8aYTqRQfJxP50nMQXE4ICOQqU6UEPKQjPbMCTkN4SuWEpg8JicwEQyETEfkc4HrvrJd2dS08fQdXVOvbPtDp3VXrrFO3rfoSl86mt_rW7pMcqwqusCwbeqAgRY_dG67vrUVfS2rClu6pAMSzsmRt1XAi108Ix-PD8v8OZm9Pb3k01niBOgugQzS1LFJphBAIKiMTRSzDjHVVqD3BSgGTlgJRbFKudZZMRErr6TinussPSM3f3O3bfPdY-jMpgwuXmBrbPpgMsWF0kxHUP6Brm1CaNGbbVtu4qsGmBmUmkGXGXSZqNTEfFAa-652C_pig6v_rp3DCFzvABucrXxra1eGPcdBKc25SH8BnFt8yw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67247808</pqid></control><display><type>article</type><title>Regulation of Secondary Antigen-Specific CD8+ T-Cell Responses by Natural Killer T Cells</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>American Association for Cancer Research</source><creator>CHANGWAN HONG ; LEE, Hyunji ; PARK, Yoon-Kyung ; SHIN, Junghoon ; SUNDO JUNG ; KIM, Hoyeon ; HONG, Seokmann ; PARK, Se-Ho</creator><creatorcontrib>CHANGWAN HONG ; LEE, Hyunji ; PARK, Yoon-Kyung ; SHIN, Junghoon ; SUNDO JUNG ; KIM, Hoyeon ; HONG, Seokmann ; PARK, Se-Ho</creatorcontrib><description>The physiologic function of natural killer T (NKT) cells in adaptive immunity remains largely unknown because most studies have used NKT cell agonists. In the present study, the role of NKT cells during the secondary effector phase was investigated separately from the primary immunization phase via adoptive transfer of differentiated effector T cells into naive recipients. We found that secondary antitumor CD8(+) T-cell responses were optimal when NKT cells were present. Tumor-specific CD8(+) effector T cells responded less strongly to tumor cell challenge in NKT cell-deficient recipients than in recipients with intact NKT cells. NKT cell-mediated enhancement of the secondary antitumor CD8(+) T-cell response was concurrent with increased number and activity of tumor-specific CD8(+) T cells. These findings provide the first demonstration of a direct role for NKT cells in the regulation of antigen-specific secondary T-cell responses without the use of exogenous NKT cell agonists such as alpha-galactosylceramide (alpha-GalCer). Furthermore, forced activation of NKT cells with alpha-GalCer during the secondary immune response in suboptimally immunized animals enhanced otherwise poor tumor rejection responses. Taken together, our findings strongly emphasize the importance of NKT cells in secondary CD8(+) T-cell immune responses.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>DOI: 10.1158/0008-5472.CAN-08-1721</identifier><identifier>PMID: 19401453</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Adoptive Transfer ; Animals ; Antigens, CD1d - genetics ; Antigens, CD1d - immunology ; Antineoplastic agents ; Biological and medical sciences ; CD8-Positive T-Lymphocytes - immunology ; Cytotoxicity, Immunologic - immunology ; Flow Cytometry ; Immunity, Innate ; Killer Cells, Natural - immunology ; Lymphocyte Activation ; Medical sciences ; Melanoma, Experimental - immunology ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Mice, Transgenic ; Ovalbumin - genetics ; Ovalbumin - immunology ; Pharmacology. Drug treatments ; Receptors, Antigen, T-Cell - genetics ; Tumors</subject><ispartof>Cancer research (Chicago, Ill.), 2009-05, Vol.69 (10), p.4301-4308</ispartof><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c418t-16133c0967e114e1760970acee38a4effb1701c4a51bbd32886b94df7572f2863</citedby><cites>FETCH-LOGICAL-c418t-16133c0967e114e1760970acee38a4effb1701c4a51bbd32886b94df7572f2863</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,3345,27911,27912</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21778224$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19401453$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>CHANGWAN HONG</creatorcontrib><creatorcontrib>LEE, Hyunji</creatorcontrib><creatorcontrib>PARK, Yoon-Kyung</creatorcontrib><creatorcontrib>SHIN, Junghoon</creatorcontrib><creatorcontrib>SUNDO JUNG</creatorcontrib><creatorcontrib>KIM, Hoyeon</creatorcontrib><creatorcontrib>HONG, Seokmann</creatorcontrib><creatorcontrib>PARK, Se-Ho</creatorcontrib><title>Regulation of Secondary Antigen-Specific CD8+ T-Cell Responses by Natural Killer T Cells</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>The physiologic function of natural killer T (NKT) cells in adaptive immunity remains largely unknown because most studies have used NKT cell agonists. In the present study, the role of NKT cells during the secondary effector phase was investigated separately from the primary immunization phase via adoptive transfer of differentiated effector T cells into naive recipients. We found that secondary antitumor CD8(+) T-cell responses were optimal when NKT cells were present. Tumor-specific CD8(+) effector T cells responded less strongly to tumor cell challenge in NKT cell-deficient recipients than in recipients with intact NKT cells. NKT cell-mediated enhancement of the secondary antitumor CD8(+) T-cell response was concurrent with increased number and activity of tumor-specific CD8(+) T cells. These findings provide the first demonstration of a direct role for NKT cells in the regulation of antigen-specific secondary T-cell responses without the use of exogenous NKT cell agonists such as alpha-galactosylceramide (alpha-GalCer). Furthermore, forced activation of NKT cells with alpha-GalCer during the secondary immune response in suboptimally immunized animals enhanced otherwise poor tumor rejection responses. Taken together, our findings strongly emphasize the importance of NKT cells in secondary CD8(+) T-cell immune responses.</description><subject>Adoptive Transfer</subject><subject>Animals</subject><subject>Antigens, CD1d - genetics</subject><subject>Antigens, CD1d - immunology</subject><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>CD8-Positive T-Lymphocytes - immunology</subject><subject>Cytotoxicity, Immunologic - immunology</subject><subject>Flow Cytometry</subject><subject>Immunity, Innate</subject><subject>Killer Cells, Natural - immunology</subject><subject>Lymphocyte Activation</subject><subject>Medical sciences</subject><subject>Melanoma, Experimental - immunology</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Mice, Transgenic</subject><subject>Ovalbumin - genetics</subject><subject>Ovalbumin - immunology</subject><subject>Pharmacology. Drug treatments</subject><subject>Receptors, Antigen, T-Cell - genetics</subject><subject>Tumors</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkMlOwzAQQC0EgrJ8AsgXuKAUj2PH7rEKq6iKVIrEzXLccRWUJiVODvw9jqjKaWakN9sj5BLYGEDqO8aYTqRQfJxP50nMQXE4ICOQqU6UEPKQjPbMCTkN4SuWEpg8JicwEQyETEfkc4HrvrJd2dS08fQdXVOvbPtDp3VXrrFO3rfoSl86mt_rW7pMcqwqusCwbeqAgRY_dG67vrUVfS2rClu6pAMSzsmRt1XAi108Ix-PD8v8OZm9Pb3k01niBOgugQzS1LFJphBAIKiMTRSzDjHVVqD3BSgGTlgJRbFKudZZMRErr6TinussPSM3f3O3bfPdY-jMpgwuXmBrbPpgMsWF0kxHUP6Brm1CaNGbbVtu4qsGmBmUmkGXGXSZqNTEfFAa-652C_pig6v_rp3DCFzvABucrXxra1eGPcdBKc25SH8BnFt8yw</recordid><startdate>20090515</startdate><enddate>20090515</enddate><creator>CHANGWAN HONG</creator><creator>LEE, Hyunji</creator><creator>PARK, Yoon-Kyung</creator><creator>SHIN, Junghoon</creator><creator>SUNDO JUNG</creator><creator>KIM, Hoyeon</creator><creator>HONG, Seokmann</creator><creator>PARK, Se-Ho</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20090515</creationdate><title>Regulation of Secondary Antigen-Specific CD8+ T-Cell Responses by Natural Killer T Cells</title><author>CHANGWAN HONG ; LEE, Hyunji ; PARK, Yoon-Kyung ; SHIN, Junghoon ; SUNDO JUNG ; KIM, Hoyeon ; HONG, Seokmann ; PARK, Se-Ho</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-16133c0967e114e1760970acee38a4effb1701c4a51bbd32886b94df7572f2863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adoptive Transfer</topic><topic>Animals</topic><topic>Antigens, CD1d - genetics</topic><topic>Antigens, CD1d - immunology</topic><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>CD8-Positive T-Lymphocytes - immunology</topic><topic>Cytotoxicity, Immunologic - immunology</topic><topic>Flow Cytometry</topic><topic>Immunity, Innate</topic><topic>Killer Cells, Natural - immunology</topic><topic>Lymphocyte Activation</topic><topic>Medical sciences</topic><topic>Melanoma, Experimental - immunology</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Mice, Transgenic</topic><topic>Ovalbumin - genetics</topic><topic>Ovalbumin - immunology</topic><topic>Pharmacology. Drug treatments</topic><topic>Receptors, Antigen, T-Cell - genetics</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CHANGWAN HONG</creatorcontrib><creatorcontrib>LEE, Hyunji</creatorcontrib><creatorcontrib>PARK, Yoon-Kyung</creatorcontrib><creatorcontrib>SHIN, Junghoon</creatorcontrib><creatorcontrib>SUNDO JUNG</creatorcontrib><creatorcontrib>KIM, Hoyeon</creatorcontrib><creatorcontrib>HONG, Seokmann</creatorcontrib><creatorcontrib>PARK, Se-Ho</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CHANGWAN HONG</au><au>LEE, Hyunji</au><au>PARK, Yoon-Kyung</au><au>SHIN, Junghoon</au><au>SUNDO JUNG</au><au>KIM, Hoyeon</au><au>HONG, Seokmann</au><au>PARK, Se-Ho</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Regulation of Secondary Antigen-Specific CD8+ T-Cell Responses by Natural Killer T Cells</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>2009-05-15</date><risdate>2009</risdate><volume>69</volume><issue>10</issue><spage>4301</spage><epage>4308</epage><pages>4301-4308</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><abstract>The physiologic function of natural killer T (NKT) cells in adaptive immunity remains largely unknown because most studies have used NKT cell agonists. In the present study, the role of NKT cells during the secondary effector phase was investigated separately from the primary immunization phase via adoptive transfer of differentiated effector T cells into naive recipients. We found that secondary antitumor CD8(+) T-cell responses were optimal when NKT cells were present. Tumor-specific CD8(+) effector T cells responded less strongly to tumor cell challenge in NKT cell-deficient recipients than in recipients with intact NKT cells. NKT cell-mediated enhancement of the secondary antitumor CD8(+) T-cell response was concurrent with increased number and activity of tumor-specific CD8(+) T cells. These findings provide the first demonstration of a direct role for NKT cells in the regulation of antigen-specific secondary T-cell responses without the use of exogenous NKT cell agonists such as alpha-galactosylceramide (alpha-GalCer). Furthermore, forced activation of NKT cells with alpha-GalCer during the secondary immune response in suboptimally immunized animals enhanced otherwise poor tumor rejection responses. Taken together, our findings strongly emphasize the importance of NKT cells in secondary CD8(+) T-cell immune responses.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>19401453</pmid><doi>10.1158/0008-5472.CAN-08-1721</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-5472 |
ispartof | Cancer research (Chicago, Ill.), 2009-05, Vol.69 (10), p.4301-4308 |
issn | 0008-5472 1538-7445 |
language | eng |
recordid | cdi_proquest_miscellaneous_67247808 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; American Association for Cancer Research |
subjects | Adoptive Transfer Animals Antigens, CD1d - genetics Antigens, CD1d - immunology Antineoplastic agents Biological and medical sciences CD8-Positive T-Lymphocytes - immunology Cytotoxicity, Immunologic - immunology Flow Cytometry Immunity, Innate Killer Cells, Natural - immunology Lymphocyte Activation Medical sciences Melanoma, Experimental - immunology Mice Mice, Inbred C57BL Mice, Knockout Mice, Transgenic Ovalbumin - genetics Ovalbumin - immunology Pharmacology. Drug treatments Receptors, Antigen, T-Cell - genetics Tumors |
title | Regulation of Secondary Antigen-Specific CD8+ T-Cell Responses by Natural Killer T Cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T11%3A05%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Regulation%20of%20Secondary%20Antigen-Specific%20CD8+%20T-Cell%20Responses%20by%20Natural%20Killer%20T%20Cells&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=CHANGWAN%20HONG&rft.date=2009-05-15&rft.volume=69&rft.issue=10&rft.spage=4301&rft.epage=4308&rft.pages=4301-4308&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/10.1158/0008-5472.CAN-08-1721&rft_dat=%3Cproquest_cross%3E67247808%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67247808&rft_id=info:pmid/19401453&rfr_iscdi=true |